Davis R M Inc. cut its stake in McKesson Co. (NYSE:MCK – Free Report) by 7.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 865 shares of the company’s stock after selling 71 shares during the quarter. Davis R M Inc.’s holdings in McKesson were worth $464,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of MCK. Dynamic Advisor Solutions LLC bought a new position in shares of McKesson during the fourth quarter valued at approximately $243,000. BKM Wealth Management LLC bought a new position in shares of McKesson during the fourth quarter valued at approximately $31,000. Cedar Brook Financial Partners LLC bought a new position in shares of McKesson during the fourth quarter valued at approximately $227,000. SG Americas Securities LLC increased its stake in shares of McKesson by 19.2% during the fourth quarter. SG Americas Securities LLC now owns 9,462 shares of the company’s stock valued at $4,381,000 after purchasing an additional 1,525 shares in the last quarter. Finally, GPS Wealth Strategies Group LLC increased its stake in shares of McKesson by 16.0% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 746 shares of the company’s stock valued at $345,000 after purchasing an additional 103 shares in the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on MCK shares. UBS Group raised their target price on shares of McKesson from $620.00 to $630.00 and gave the company a “buy” rating in a research note on Wednesday, May 8th. Morgan Stanley raised their target price on shares of McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. Wells Fargo & Company raised their price target on shares of McKesson from $502.00 to $551.00 and gave the company an “equal weight” rating in a research report on Thursday, May 9th. Argus raised their price target on shares of McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Finally, Evercore ISI raised their price target on shares of McKesson from $600.00 to $660.00 and gave the company an “outperform” rating in a research report on Tuesday, July 9th. Two equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $599.33.
Insiders Place Their Bets
In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $580.92, for a total transaction of $2,180,192.76. Following the transaction, the chief executive officer now owns 86,092 shares in the company, valued at approximately $50,012,564.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Maria Martinez sold 483 shares of McKesson stock in a transaction on Friday, June 7th. The shares were sold at an average price of $585.88, for a total transaction of $282,980.04. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Wednesday, July 3rd. The stock was sold at an average price of $580.92, for a total transaction of $2,180,192.76. Following the transaction, the chief executive officer now owns 86,092 shares in the company, valued at approximately $50,012,564.64. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,567 shares of company stock valued at $16,691,841. Company insiders own 0.11% of the company’s stock.
McKesson Trading Up 0.5 %
NYSE:MCK traded up $2.82 during trading hours on Tuesday, reaching $585.82. The company had a trading volume of 207,127 shares, compared to its average volume of 698,449. McKesson Co. has a 52 week low of $395.30 and a 52 week high of $612.17. The firm has a market cap of $76.12 billion, a price-to-earnings ratio of 26.14, a PEG ratio of 1.35 and a beta of 0.45. The firm’s 50 day moving average price is $579.77 and its 200-day moving average price is $539.70.
McKesson (NYSE:MCK – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $6.18 EPS for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The company had revenue of $76.36 billion during the quarter, compared to the consensus estimate of $79.32 billion. During the same period last year, the firm posted $7.19 EPS. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, analysts forecast that McKesson Co. will post 31.67 earnings per share for the current fiscal year.
McKesson Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, July 1st. Shareholders of record on Monday, June 3rd were given a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date of this dividend was Monday, June 3rd. McKesson’s dividend payout ratio (DPR) is presently 11.08%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
- Energy and Oil Stocks Explained
- Leading Beverage Company’s Stock Bubbles Higher: Rally Ahead
- Top Biotech Stocks: Exploring Innovation Opportunities
- Can This Meme Stock Stage One Last Rally?
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.